TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/21/10 10:28 | 12/20/10 | VRUS | Pharmasset Inc | Health | Drug | Pharmaceutical Preparations | Hahn Elliot F | NJ | D | M.d | 796 | 18.47 | 0 | 43 | 58 | 117 | D | ||||||||||||||||
10/1/10 16:07 | 9/30/10 | VRUS | Pharmasset Inc | Health | Drug | Pharmaceutical Preparations | Hahn Elliot F | NJ | D | M.d | 94 | 3.79 | 0 | 25 | 50 | 74 | D | ||||||||||||||||
9/21/10 12:12 | 9/17/10 | VRUS | Pharmasset Inc | Health | Drug | Pharmaceutical Preparations | Hahn Elliot F | NJ | D | M.d | 160 | 5.33 | 0 | 30 | 155 | 49 | D | ||||||||||||||||
12/8/04 17:03 | 12/6/04 | ABRX | Able Laboratories Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hahn Elliot F | NJ | D | M.d | 86 | 11.50 | 0 | 8 | 38 | 28 | D | |||||||||||||||
8/24/04 16:56 | 8/20/04 | ABRX | Able Laboratories Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hahn Elliot F | NJ | D | M.d | 230 | 11.50 | 0 | 20 | New | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |